Development of OPN-305 as an orphan drug for the treatment of Delayed Graft Function post solid organ transplantation

Project Information

MABSOT

Grant agreement ID: 261468

Project closed

Start date 1 December 2010

End date 30 September 2014

Funded under

• Specific Programme "Cooperation": Health

Total cost € 7 844 900,20

EU contribution € 5 929 064,00

Coordinated by

OPSONA THERAPEUTICS LIMITED
Ireland